3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
16
Carcinoma, Renal Cell
13
Carcinoma, Non-Small-Cell Lung
7
Neoplasm Metastasis
6
Clear-cell metastatic renal cell carcinoma
6
Lung Neoplasms
5
Prostatic Neoplasms
4
Brain Neoplasms
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Histiocytoma, Malignant Fibrous
3
Carcinoma, Transitional Cell
3
Carcinoma, Basal Cell
3
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Rectal Neoplasms
2
Penile Neoplasms
2
Nasopharyngeal Carcinoma
2
Meningioma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Glioblastoma
2
Carcinoma, Merkel Cell
2
Interventions
Rituximab
7
Vemurafenib
4
Cyclophosphamide
4
Cladribine
4
Specimen Handling
3
Biopsy
3
obinutuzumab
2
ibrutinib
2
fludarabine phosphate
2
fludarabine
2
binimetinib
2
Diphenhydramine
2
Dexamethasone
2
Calcium Dobesilate
2
CT-P10
2
Acetaminophen
2
venetoclax
1
tovorafenib
1
polatuzumab vedotin
1
pembrolizumab
1
immunotoxin HA22
1
encorafenib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
brexucabtagene autoleucel
1
auricularum
1
acalabrutinib
1
Whole-Body Irradiation
1
Valganciclovir
1
Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Hairy Cell
×
CTLA-4 Antigen
×
1 year
×
Clear all
No trials found.